Flywheel Private Wealth LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 567 shares of the healthcare conglomerate’s stock, valued at approximately $287,000.
A number of other large investors have also modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the 3rd quarter worth about $27,000. Global Wealth Strategies & Associates raised its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $32,000. Quarry LP raised its position in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on UNH shares. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Cantor Fitzgerald lifted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. KeyCorp began coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $626.79.
UnitedHealth Group Stock Down 0.1 %
Shares of NYSE:UNH opened at $543.21 on Thursday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $499.91 billion, a price-to-earnings ratio of 35.39, a PEG ratio of 1.42 and a beta of 0.62. The business has a 50-day moving average price of $554.45 and a 200 day moving average price of $563.12. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- 3 Warren Buffett Stocks to Buy Now
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.